Production (Stage)
Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.11% | -3.97% | -21.58% | -23.60% | -27.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.11% | -3.97% | -21.58% | -23.60% | -27.98% |
| Cost of Revenue | 3.80% | 4.33% | 5.38% | 5.41% | 1.96% |
| Gross Profit | 28.00% | -7.84% | -32.12% | -34.31% | -38.46% |
| SG&A Expenses | -6.34% | -20.33% | -30.93% | -30.57% | -32.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 109.59% | 54.39% | -69.85% | -108.53% | -146.44% |
| Total Operating Expenses | 20.61% | -0.80% | -17.74% | -21.76% | -28.01% |
| Operating Income | -24.46% | -8.10% | 6.26% | 16.65% | 28.07% |
| Income Before Tax | -44.42% | -38.84% | -32.21% | -23.42% | -11.71% |
| Income Tax Expenses | -- | -- | -- | 0.00% | 100.00% |
| Earnings from Continuing Operations | -44.43% | -38.81% | -32.11% | -23.42% | -11.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.43% | -38.81% | -32.11% | -23.42% | -11.79% |
| EBIT | -24.46% | -8.10% | 6.26% | 16.65% | 28.07% |
| EBITDA | -27.58% | -7.07% | 9.68% | 20.27% | 31.58% |
| EPS Basic | 25.00% | 35.29% | 44.44% | 31.58% | 23.81% |
| Normalized Basic EPS | 50.00% | 60.00% | 66.67% | 53.85% | 42.86% |
| EPS Diluted | 25.00% | 35.29% | 44.44% | 31.58% | 23.81% |
| Normalized Diluted EPS | 50.00% | 60.00% | 66.67% | 53.85% | 42.86% |
| Average Basic Shares Outstanding | 60.32% | 94.94% | 153.28% | 113.25% | 72.32% |
| Average Diluted Shares Outstanding | 60.32% | 94.94% | 153.28% | 113.25% | 72.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |